Hikma Pharmaceuticals PLC
HKMPY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $6 | $5 | $4 | $7 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $7 | $6 | $5 | $7 |
| Revenue | $3 | $3 | $3 | $3 |
| % Growth | 8.8% | 14.2% | -1.4% | – |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 45.3% | 48.9% | 49.2% | 51% |
| EBITDA | $1 | $1 | $1 | $1 |
| % Margin | 23.2% | 19.4% | 27.3% | 30% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 11.5% | 6.6% | 7.5% | 16.5% |
| EPS Diluted | 3.22 | 1.72 | 1.68 | 3.62 |
| % Growth | 87.2% | 2.4% | -53.6% | – |
| Operating Cash Flow | $1 | $1 | $1 | $1 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |